| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: disclosed is a method of treating or preventing malignant tumours whose cells express EphA4. The method involves administration of the anti-EphA4 antibody, where the antibody has human IgG1, has VH and VL regions, each containing three corresponding CDR. Described is a pharmaceutical composition based on the antibody for use in the said method. ^ EFFECT: invention can be used in pancreatic cancer therapy. ^ 11 cl, 2 dwg, 1 tbl, 1 ex |
